- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03480204
Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY
February 15, 2019 updated by: Dan Cantillon, The Cleveland Clinic
This study evaluates the feasibility and usability of a wearable patch as a cardiac monitor for non-ICU hospitalized patients.
Study Overview
Status
Completed
Conditions
Detailed Description
This study evaluates the feasibility and usability of a wearable patch cardiac monitor, gateway and server concomitant with standard-of-care cardiac telemetry monitoring for non-ICU hospitalized patients on a selected nursing ward at the Cleveland Clinic Heart and Vascular Institute.
All patients will receive routine clinical care on the basis of the traditional telemetry monitoring using the usual processes.
The patch monitor data will not be reviewed in real-time, and only analyzed post hoc for agreement with the standard-of-care.
Study Type
Observational
Enrollment (Actual)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Non-ICU hospitalized patients on the J8-3 nursing ward at the Cleveland Clinic Heart and Vascular Institute
Description
Inclusion Criteria:
- >= 18 years old and able to provide informed consent
- Standard indication for cardiac telemetry monitoring (institutional standardized criteria) with valid electronic order
Exclusion Criteria:
- Cardiac implantable device (pacemaker or ICD)
- Contact precautions or isolation
- Telemetry discontinuation planned within 12 hours (i.e. anticipated discharge)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Connectivity
Time Frame: 48 hours
|
Successful patch application by nursing, and transmission of cardiac waveform data to gateway and then to offline secure server
|
48 hours
|
|
Continuity
Time Frame: 48 hours
|
Loss of cardiac waveform signal from patch compared with traditional telemetry monitor.
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Agreement for cardiac arrhythmia detection (post hoc, offline)
Time Frame: 48 hours
|
Analysis of cardiac arrhythmia detections on patch compared with traditional telemetry for agreement, concordance and discordance.
|
48 hours
|
|
Body temperature (post hoc, offline)
Time Frame: 48 hours
|
Body temperature recorded by patch compared with nursing documentation in a post hoc analysis.
Data from patch will not be assessed for patient care in real time.
|
48 hours
|
|
Cardiac waveform (post hoc, offline)
Time Frame: 48 hours
|
Pre-specified analysis of cardiac waveform characteristics in association with pre-specified clinical events such as deployment of emergency response team.
|
48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 19, 2018
Primary Completion (Actual)
December 23, 2018
Study Completion (Actual)
December 23, 2018
Study Registration Dates
First Submitted
March 21, 2018
First Submitted That Met QC Criteria
March 21, 2018
First Posted (Actual)
March 29, 2018
Study Record Updates
Last Update Posted (Actual)
February 19, 2019
Last Update Submitted That Met QC Criteria
February 15, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-1656
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Arrhythmia
-
Medical University of LodzNot yet recruitingCardiac Arrhythmia | Supraventricular ArrhythmiaPoland
-
Myant Medical Corp.Partners in Advanced Cardiac EvaluationRecruiting
-
Myant Medical Corp.Partners in Advanced Cardiac EvaluationCompleted
-
New York Institute of TechnologyCompleted
-
Kansas City Heart Rhythm InstituteBiosense Webster, Inc.TerminatedArrhythmia, CardiacUnited States
-
Paris Sudden Death Expertise CenterHospices Civils de Lyon; University Hospital, Strasbourg, France; University... and other collaboratorsRecruitingDefibrillators, Implantable | Sudden Cardiac Death Due to Cardiac ArrhythmiaFrance
-
Children's National Research InstituteNational Institutes of Health (NIH)CompletedVentricular Tachycardia | Cardiac ArrhythmiaUnited States
-
Imperial College LondonImperial College Healthcare NHS TrustRecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Fibrillation, Persistent | Cardiac ArrhythmiaUnited Kingdom
-
SanofiCompletedVentricular Arrhythmia | Arrhythmia ProphylaxisNetherlands, Spain, Belgium, Japan, Finland, Chile, Australia, United States, Argentina, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa and more
-
Adana City Training and Research HospitalCompleted